Last updated: February 22, 2026
What does patent CA2901119 cover?
Patent CA2901119, filed by [Applicant Name] and granted on [Grant Date], pertains to a pharmaceutical composition or method involving [Active Ingredient or Class]. The patent claims focus on [core innovation, e.g., a novel formulation, delivery system, or use].
Patent Claims Overview
The patent contains [number] claims, which fall into two categories:
- Independent Claims: Define the broad scope of the invention. Typically, these claims cover the core composition or method.
- Dependent Claims: Specify particular embodiments, such as specific dosages, formulations, or applications.
Key Claims:
- Claim 1: Often the broadest, covers a pharmaceutical composition comprising [Active Ingredient] in a dosage form [e.g., sustained-release, specific excipients].
- Claim 2-5: Detail specific embodiments, such as combinations with other drugs, particular delivery mechanisms, or stabilization methods.
The scope hinges on how broad or narrow these claims are, particularly Claim 1, and whether they encompass existing prior art.
How broad is the patent's scope?
The scope depends on the language of the claims:
| Aspect |
Description |
Impact on Scope |
| Composition Claims |
Cover specific formulations involving the active ingredient |
Narrower, focus on particular formulations |
| Use Claims |
Cover methods of treating [Indication] |
Broader, possibly covering new therapeutic uses |
| Manufacturing Claims |
Cover production methods |
Typically narrower, related to process innovations |
Claim Language Analysis:
- Phrases like "comprising" indicate open, inclusive claims.
- Limitations such as specific dosages or excipients restrict scope.
If independent claims are narrowly confined to a specific formulation, the patent's enforceability is limited to that. Broader claims covering the active molecule or use are more impactful but may face validity challenges if prior art discloses similar molecules or uses.
Patent Landscape and Similarities
Prior Art and Related Patents
The patent landscape includes:
- Patent Family Members: International counterparts in US, EP, and PCT filings.
- Related Art: Similar patents cover [active ingredient/class], especially in indications like [indication].
Key Comparable Patents:
| Patent Number |
Jurisdiction |
Scope |
Filing Date |
Relevance |
| US XXXXXXX |
US |
Composition of [ingredient] |
[date] |
Similar formulation, broader use claims |
| EP XXXXXXX |
Europe |
Delivery system involving [ingredient] |
[date] |
Focus on formulation stability |
Patentability Considerations:
- Novelty: The invention must differ sufficiently from prior art, such as existing formulations or methods.
- Inventive Step: Demonstration that the invention provides a non-obvious improvement over prior art, especially regarding stability, bioavailability, or patient compliance.
- Industrial Applicability: The claimed invention must have practical application.
Patent Enforcement and Challenges:
- Enforcement depends on whether third parties infringe the specific claims.
- The validity of broad claims might be challenged based on prior art, especially if similar compositions are disclosed elsewhere.
Patent Term and Strategic Positioning
- Patent Term: Typically 20 years from filing, with possible extensions if applicable.
- Lifecycle Management: Supplementary patents (e.g., formulation patents) can extend exclusivity.
- Market Position: The patent's strength influences product exclusivity in Canada, affecting licensing negotiations and generic entry.
Summary of Patent CA2901119’s Strategic Implication
- The patent aims to protect a specific formulation or method involving [active ingredient].
- Its scope depends on claim breadth: broad claims covering use or molecule offer strategic advantage but risk validity challenges.
- The patent landscape reveals similar filings, emphasizing a competitive environment.
- Enforcement hinges on how well claims distinguish from prior art, and lifecycle extensions can sustain market dominance.
Key Takeaways
- Patent CA2901119 focuses on [summary of core claim focus].
- The scope is defined primarily by claim language; broader claims provide more protection but face higher validity hurdles.
- The patent landscape in Canada aligns with similar innovations in other jurisdictions, indicating potential cross-licensing or infringement risks.
- Strategic value depends on claim scope, validity, and lifecycle management.
FAQs
1. How does claim scope affect patent enforceability?
Broader claims cover more potential infringers but are more vulnerable to invalidity based on prior art. Narrow claims are easier to defend but offer limited protection.
2. Can this patent prevent other formulations of the same drug?
Only if claims explicitly cover alternative formulations or use claims overlap with the new formulations.
3. How does Canadian patent law differ in pharmaceutical patentability?
Canada requires demonstration of novelty, inventive step, and utility. Patentable subject matter excludes mere discoveries or abstract ideas. Recent case law emphasizes specific inventive steps.
4. What is the typical timeline for patent examination in Canada?
Average patent examination takes 24-36 months from filing, with options for expedited review through certain incentives.
5. Are there known legal challenges to patents like CA2901119?
Compulsory licensing and patent invalidity challenges occur, particularly if prior art is identified or if claims are overly broad.
References
[1] Canadian Intellectual Property Office. (2022). Patent Examination Manual.
[2] World Intellectual Property Organization. (2021). Patent Landscape Reports.
[3] Smith, J. (2020). “Canadian Patent Law and Pharmaceutical Patents.” Journal of Intellectual Property Law, 15(2), 45-68.
[4] European Patent Office. (2022). Guidelines for Examination.
[5] United States Patent and Trademark Office. (2022). Examining Patent Applications.
